EUVIMEDEUVIMED entdecken
Open Access

Design of the Continuous Glucose Monitoring (CGM) Study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM)

Dan Wang, Scott Z Mu, Olive Tang, Justin B Echouffo-Tcheugui, Christine M Mitchell, Michael Fang, Mary R Rooney, Hsin-Chieh Yeh, Casey M Rebholz, Scott J Pilla, Lawrence J Appel, Elizabeth Selvin

Contemporary Clinical Trials · 2025

DOI: 10.1016/j.cct.2025.107845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2025. Verfasst von Dan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21287, USA; Welch Center for Prevention, Epidemiology, and…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Dietary Approaches To Stop Hypertension, Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The Dietary Approaches to Stop Hypertension (DASH) diet is recommended for adults with diabetes. However, the effects of the DASH diet on glucose control and variability have not been thoroughly investigated. STUDY AIM: To study the effects of a modified DASH diet on glycemic control and glucose variability assessed by continuous glucose monitoring (CGM) in individuals with hypertension and type 2 diabetes. METHODS: We conducted an ancillary study to add CGM to the Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) Trial. The DASH4D Trial was designed to determine the effects, alone and combined, of a modified DASH diet (vs a diet typical of what Americans with diabetes eat) and lower (vs higher) sodium intake on systolic blood pressure among people with type 2 diabetes and elevated blood pressure. Participants were fed each of the 4 study diets for 5 weeks in a random order. We invited all participants enrolling in the DASH4D Trial to wear a masked CGM sensor for up to 14 days during screening and during each of the four 5-week feeding periods. The DASH4D-CGM Study primarily aimed to evaluate the effects of the modified DASH diet (vs comparison diet) on glycemic control (mean glucose and time-in-range) and glucose variability (coefficient of variation). CONCLUSION: Combining CGM technology and a controlled feeding design, the DASH4D-CGM Study will generate robust data on the effects of diet on glycemic control and variability. These findings will inform dietary recommendations for adults with type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Dietary Approaches To Stop HypertensionHypertensionAdultAgedFemaleHumansMaleMiddle AgedBlood GlucoseBlood Glucose Self-MonitoringBlood PressureContinuous Glucose MonitoringGlycemic ControlRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Continuous glucose monitoring (CGM)Cross-over designRandomized controlled feeding trialReal-time hypoglycemia symptom reportingType 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21287, USA; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA.
  • Department of General Surgery, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Johns Hopkins Hospital and Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21287, USA; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD 21287, USA…
  • Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public…

Förderung

  • NIMHD NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Institute on Minority Health and Health Disparities
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Wang, D., Mu, S. Z., Tang, O., Echouffo-Tcheugui, J. B., Mitchell, C. M., Fang, M., Rooney, M. R., Yeh, H. C., Rebholz, C. M., Pilla, S. J., Appel, L. J., & Selvin, E. (2025). Design of the Continuous Glucose Monitoring (CGM) Study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM). Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2025.107845

Vancouver

Wang D, Mu SZ, Tang O, Echouffo-Tcheugui JB, Mitchell CM, Fang M, et al. Design of the Continuous Glucose Monitoring (CGM) Study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM). Contemporary Clinical Trials. 2025. doi:10.1016/j.cct.2025.107845

BibTeX
@article{Wang2025,
  author = {Wang, Dan and Mu, Scott Z and Tang, Olive and Echouffo-Tcheugui, Justin B and Mitchell, Christine M and Fang, Michael and Rooney, Mary R and Yeh, Hsin-Chieh and Rebholz, Casey M and Pilla, Scott J and Appel, Lawrence J and Selvin, Elizabeth},
  title = {Design of the Continuous Glucose Monitoring (CGM) Study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM)},
  journal = {Contemporary Clinical Trials},
  year = {2025},
  doi = {10.1016/j.cct.2025.107845}
}
Kostenlos starten →